4//SEC Filing
Mazur-Hofsaess Katarzyna 4
Accession 0000911916-18-000127
CIK 0001136869other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:05 PM ET
Size
8.8 KB
Accession
0000911916-18-000127
Insider Transaction Report
Form 4
Mazur-Hofsaess Katarzyna
Pres., Eur., M. East & Afr.
Transactions
- Exercise/Conversion
Common Stock
2018-05-22$73.15/sh+8,765$641,160→ 25,447 total - Sale
Common Stock
2018-05-22$113.61/sh−8,765$995,795→ 16,682 total - Exercise/Conversion
Employee Stock Option (right to buy)
2018-05-22−8,765→ 0 totalExercise: $73.15Exp: 2023-03-18→ Common Stock (8,765 underlying)
Footnotes (2)
- [F1]Represents the sale of 8,765 shares in multiple transactions ranging in price from $113.30 to $114.14 per share, resulting in a weighted average sale price of $113.6104. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- [F2]Vested annually over four years in increments of 25% each year, commencing on March 18, 2014.
Documents
Issuer
ZIMMER BIOMET HOLDINGS, INC.
CIK 0001136869
Entity typeother
Related Parties
1- filerCIK 0001574684
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 5:05 PM ET
- Size
- 8.8 KB